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Abstract 
 
Antimicrobial resistance (AMR) represents one of the major health threats faced by humanity 
over the next few years. To prevent a global epidemic of antimicrobial-resistant infections, 
the discovery of new antimicrobials and antibiotics, better anti-infection strategies and 
diagnostics, and changes to our current use of antibiotics have all become of paramount 
importance. Numerous studies investigating the bioactivities of seaweed extracts as well as 
their secondary and primary metabolites highlight the vast biochemical diversity of seaweeds, 
with new modes of action making them ideal sources for the discovery of novel antimicrobial 
bioactive compounds of pharmaceutical interest. In recent years, researchers have focused on 
characterizing the endophytic and epiphytic microbiomes of various algal species in an 
attempt to elucidate host-microbe interactions as well as to understand the function of 
microbial communities. Although environmental and host-associated factors crucially shape 
microbial composition, microbial mutualistic and obligate symbionts are often found to play a 
fundamental role in regulating many aspects of host fitness involving ecophysiology and 
metabolism. In particular, algal “core” epiphytic bacterial communities play an important role 
in the protection of surfaces from biofouling, pathogens and grazers through the production of 
bioactive metabolites. Together, marine macroalgae and their associated microbiomes 
represent unique biological systems offering great potential for the isolation and identification 
of novel compounds and strategies to contrast the rise and dissemination of AMR. 
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marine, microbiome, pathogens, resistance, seaweeds 
 
 
Page 2 of 64
URL: http:/mc.manuscriptcentral.com/tejp  Email: ejp@nhm.ac.uk
European Journal of Phycology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
 3
Introduction 
The emergence of antimicrobial resistance (AMR) in bacteria is an ancient natural process 
(D'Costa et al., 2011) resulting from the perpetual selection of new traits evolving as a result 
of mutation (Livermore, 2002), gradual increases in tolerance to sub-lethal concentrations of 
biocides (Scenihr, 2009) and horizontal gene transfer through transformation, transduction, 
recombination and conjugation events (Furuya & Lowy, 2006). Despite the undeniable 
contribution of antibiotic use to the development of a much healthier modern society, the 
release of large quantities of antibiotics into the environment as a result of their manufacture 
at an industrial global scale for use in the clinical setting and for agriculture and animal care 
has increased the selective pressure on bacterial human pathogens (Busetti et al., 2014). As a 
result, in the clinical setting the link between antibiotic use and the generation and 
dissemination of resistant and multi-resistant strains is well established (Hawkey, 2008; 
Wellington et al., 2013). The world faces an emerging epidemic of antibiotic-resistant 
infections, the second-leading cause of premature death worldwide (Spellberg et al., 2008). 
Without effective solutions to confront AMR, by 2050, 10 million lives a year and more than 
100 trillion USD of economic output world-wide could be at risk due to the rise of drug-
resistant infections (O'Neill, 2014).  This article reviews the role of microbial biofilms in 
infection and the acquisition of resistance, examines the processes involved in the 
development and maintenance of microbial biofilms with a particular focus on the role of 
quorum sensing, discusses antimicrobial bioacti es obtained from marine organisms, and 
reviews the current state of knowledge of marine macroalgae and their associated 
microbiomes as a source of antimicrobial chemical diversity 
 
Biofilms  
Biofilms, consortia of surface-attached microbial cells immersed in a self-secreted 
extracellular polymeric matrix (Costerton et al., 1978; Donlan, 2002), constitute the principal 
form of microbial growth in almost all natural and pathogenic environments and a widespread 
survival strategy amongst microorganisms (O'Toole, 2011; Nett et al., 2012). The National 
Institutes of Health (NIH) estimates that up to 80% of all human infections implicate 
microbial biofilms (Davies, 2003; Wu et al., 2015). In fact, biofilm aetiology has been 
described as the root cause of a majority of chronic and recurrent human infections and in 
almost all device-associated infections (Wu et al., 2015; Justin & Melander, 2009; Harrison et 
al., 2010; Hoiby et al., 2011). Microbial biofilms favour both spontaneous mutation and 
vertical evolution of resistance genes (Savage et al., 2013) as well as the intra- and inter-
specific transmission and exchange of genetic components like plasmids harbouring 
resistance genes through horizontal gene transfer mechanisms (such as transformation, 
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conjugation and transduction) and the consequent dissemination of resistance genes 
(Appelbaum, 2007). For example, within biofilms, bacteria have been shown to use 
transposable elements to acquire resistance and develop multi-resistance (Ready et al., 2002). 
The emergence of multiple-antibiotic-resistant strains amongst pathogens normally present in 
the hospital environment is of particular concern and over a decade ago hospital-acquired 
infections were estimated to be responsible for an additional annual health care cost of £986 
million in England and Wales alone (Plowman, 2000, Plowman et al., 2001). In light of the 
role of bacterial biofilms in infection and dissemination of AMR, the isolation and 
characterization of novel antibiofilm bioactives as well as the identification of novel 
therapeutic approaches is crucial.  
Within biofilms, both Gram positive and Gram negative bacteria use quorum sensing 
(QS), a type of cell-to-cell communication based on the release and detection of small 
signalling compounds, to coordinate multicellular behaviour and control a wide variety of 
physiological activities (Papenfort & Bassler, 2016). Some bacterial species use QS to 
coordinate the transcription and translation of unrelated genetic loci. For instance, the 
opportunistic human pathogen Pseudomonas aeruginosa uses two hierarchically organized 
LuxI/LuxR type homologue pairs generally used by some Gram negative bacteria to produce 
and respond to acyl homoserine lactones, LasI/LasR and Rh1I/Rh1R, to control 170-400 
genes via a complex network (Hentzer et al., 2002; Schuster et al., 2003; Wagner et al., 2003; 
Parsek & Greenberg, 2005). The synchronized synthesis and release of gene products with 
substantially different functions suggests that QS is an adaptative response evolved to cope 
with conditions of high population density, for instance those found in associations with plant 
and metazoan hosts (Swift et al., 2001).  
 
Biofilms in the marine environment 
In marine environments all unprotected submerged surfaces are rapidly colonized by a 
succession of marine organisms in a process known as biofouling (Callow & Callow, 2002). 
Biofouling begins with the adsorption of dissolved organic matter by newly available surfaces 
and these “conditioned” surfaces are then rapidly colonized by prokaryotes and unicellular 
eukaryotes to form microbial biofilms (microfouling). In the marine environment, this stage is 
followed by macrofouling, the recruitment of invertebrate larvae and algal spores (Callow & 
Callow, 2002). Marine biofilms typically grow as diverse multi-species communities (Mueller 
et al., 2006). In the photic zone they are usually dominated by phototrophic microalgal 
consortia (Rao et al., 1997) and represent a crucial carbon source for other trophic levels, 
affecting mass transfer processes at the ecosystem level. 
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Marine microbial biofilms play a crucial role in regulating the colonisation of surfaces 
by marine microorganisms, invertebrates and algae and in some cases might be 
responsible for inducing cellular metamorphosis in some larval types (Dobretsov et al., 
2006). For example, tetrabromopyrrole, a compound produced by a Pseudoalteromonas 
bacterium, causes larval metamorphosis of the coral Acropora millepora (Tebben et al., 
2011). The complexity of the modulations of these phenomena is paralleled by the extreme 
diversity in the distribution and composition of biological and chemical species found in 
marine microbial biofilms. Experiments using monospecific biofilms (Dobretsov et al., 2006; 
Wieczorek & Todd, 1998; Qian et al., 2007) have shown an influence on the activity of the 
marine flora ascribable to the synthesis and release of antimicrobial compounds and a range 
of stimulatory signalling molecules that mostly remain  to be isolated and characterized 
(Bowman, 2007).  
 
Bioactive compounds 
A “bioactive compound” can be defined as a secondary metabolite which at low 
concentrations exerts either beneficial or harmful effects on living organisms and is therefore 
of interest for potential industrial or medical applications (Rangel-Huerta et al., 2015) .Of the 
more than 1 million natural products that have been discovered from both terrestrial and 
marine living organisms 20-25% have shown antimicrobial, antifungal, anti-protozoan, anti-
nematode, anticancer, antiviral or anti-inflammatory properties (Bérdy, 2005; Penesyan et al., 
2010 ; Newman & Cragg, 2106). The diversity of natural compounds can be ascribed to the 
process of natural selection that has driven the evolution of molecules best suited to perform 
their biological activities (Koehn & Carter, 2005). 
Natural products, chemicals produced by living organisms, are a traditional source of 
pharmacologically active compounds (Molinski et al., 2009), and continue to be a major 
inspiration for the majority of US Food and Drug Administration (FDA)-approved agents and 
for drug discovery and design. In fact, more than 60% of small molecule agents approved for 
use as drugs can be traced back to natural products such as aspirin (willow/birch), morphine 
(poppy), penicillin (fungus), Lovastatin (fungus), Adriamycin/dauxorubicin (bacterium) and 
Taxol™ (yew tree).  
Although the first indication of the presence in seawater of bacteria with an inhibitory 
effect against human pathogens such as Vibrio cholerae and Bacillus anthracis has been 
attributed to De Giaxa (1889; see Balcazar et al., 2007), the “modern” study of bioactives of 
marine origin emerged more than 70 years ago with the pioneering work of the Italian 
microbiologist Giuseppe Brotzu (Professor of Hygiene at the University of Cagliari, Italy). In 
1945 Brotzu grew cultures from seawater samples collected near a sewage outlet in Sardinia 
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(Mediterranean Sea) and tested isolates for antibiotic activity. Strong inhibitory activity by 
the fungus Cephalosporium acremonium against a broad range of pathogens led to the 
discovery of the cephalosporin family of antibiotics (Bo, 2000). Rosenfield & Zobell (1947) 
carried out the first large-scale systematic study on the antibiotic activity of marine organisms 
against B. anthracis. Spongothymidine and spongouridine extracted and identified from the 
Caribbean sponge Tethya crypta (Bergmann & Feeney, 1950, 1951) were natural nucleoside 
analogues, structurally similar to the nucleosides of nucleic acids, but containing arabinose 
rather than the typical ribose. More importantly, these marine-derived compounds displayed 
unexpected antiviral activities and became the basis for the synthesis of several antiviral and 
anticancer drugs including AZT (zidovudine; Fowler et al., 2016), commercially known as 
Retrovir® (GlaxoSmithKline), the first drug for the treatment of HIV, and Acyclovir (sold as 
Zovirax®; Han et al., 2017), used to treat infections caused by the herpes simplex virus. 
Vidarabine®, also known as Ara-A, is a synthetic purine nucleoside analogue derived from 
the marine bacterium Streptomyces antibioticus isolated from T. crypta sponges (Agrawal et 
al, 2016), used typically as an opthalmic ointment for the treatment of acute herpes 
keratoconjunctivitis (Akkaya & Ozkurt, 2016) and recurrent superficial keratitis caused by 
HSV-1 and HSV-2.  
Today marine ecosystems still largely constitute an untapped resource for 
pharmaceutical and biotechnological biodiscovery. In the marine environment, whereas 
submerged non-living surfaces rapidly become macrofouled, the living surfaces of organisms 
are comparatively free from macrofouling and are covered with a thin film of epibiotic 
bacteria (Armstrong et al., 2001). This is in part ascribable to metabolites effective as 
antifouling compounds and to the surface characteristics of marine organisms. Marine 
macroalgae (seaweeds) are known to utilize a plethora of secondary metabolites to defend 
themselves from herbivores and bacterial colonization of their exposed surfaces. For example, 
halogenated furanones produced by the red alga Delisea pulchra display antibiofilm effects 
against Bacillus subtilis (Ren et al., 2002), Escherichia coli (Ren et al., 2001) and 
Pseudomonas aeruginosa (Hentzer et al., 2002). 
Microbes growing on the surface of a host can also contribute to the host’s overall 
antifouling strategy. For example, epibiotic bacteria that colonize the surface of some 
crustacean larvae synthesize simple antimicrobial molecules that can defend the larvae from 
fungal infections (Gil-Turnes et al., 1989). Bacteria isolated from the surface of a tunicate and 
grown as biofilms hindered the attachment of barnacle and tunicate larvae (Holmstrom et al., 
1992). Moreover, the presence of epiphytic bacteria on the surface of seaweeds has been 
shown to be important for proper development, with atypical morphology observed in axenic 
culture (e.g. Marshall et al., 2006; Wichard et al., 2015), suggesting that seaweeds and their 
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epiphytic microbiome collaborate as a unified functional entity or holobiont (reviewed by 
Egan et al., 2012). 
 
Quorum sensing inhibition as a novel strategy to attenuate bacterial virulence  
An emerging approach designed to attenuate bacterial virulence (i.e. the ability to cause 
damage to living organisms via the production of virulence factors such as enzymes and 
toxins) and limit the emergence of pathogenic traits relies on interfering with cell-to-cell 
communication, processes now commonly termed “quorum quenching” and “quorum sensing 
inhibition” (QSI). In fact, the inability to co-ordinate communal behaviours can prevent 
bacterial pathogens from escaping or overcoming host immune responses and establishing an 
infection (Rasmussen & Givskov, 2006; Hentzer et al., 2003). Moreover, the ability to switch 
off virulence gene expression exogenously (Brackman et al., 2011) offers a novel strategy for 
the treatment or prevention of infection (Camara et al., 2002). Overall the use of QSIs 
represents an “antivirulence” strategy relying on the exploitation of small compounds with the 
capacity of disarming pathogens thereby rendering them harmless within their host by 
targeting precise factors (such as toxin function and delivery, virulence gene regulation, or 
cell adhesion) necessary for the establishment of an infection (Mellbye & Schuster, 2011). In 
certain species of bacteria, disruption of QS has been shown to affect biofilm formation (Irie 
& Parsek, 2008) and differentiation (Hardie & Heurlier, 2008), often rendering the biofilm 
more susceptible to treatment with biocides and antibiotics (Brackman & Coenye, 2015). For 
example, acylated homoserine lactone (AHL) QS mutants of Burkholderia cenocepacia and 
P. aeruginosa form flatter, less structured biofilm (Diggle et al., 2007) and are drastically 
impaired in their ability to maintain cells within the biofilm (Huber et al., 2001; Tomlin et al., 
2005; Yang et al., 2009). Of relevance from a strategic therapeutic perspective, QSI-based 
treatments have been shown to increase the susceptibility of bacterial biofilms to antibiotics 
both in vitro and in vivo. For example, a significantly greater percentage of infected wax moth 
Galleria mellonella larvae and C. elegans survived infection by P. aeruginosa and B. 
cenocepacia following combined treatment with antibiotic and QS inhibitors, compared to 
treatment with an antibiotic alone (Brackman et al., 2011).  
Paradoxically, the strong selective pressure imposed by the use of antibiotics in the 
clinical setting makes this environment a fertile ground for the generation and spread of 
resistant and multiresistant strains with a consequent rise in morbidity and mortality due to 
hospital-acquired infections (Hawkey, 2008). Since QS is not directly involved in essential 
processes such as cell division, one can reason that its inhibition will not generate a severe 
selective pressure likely to result in the development of resistance (Rasmussen & Givskov, 
2006; Sperandio, 2007; Kendall & Sperandio, 2007). In fact, the impairment of QS results in 
a disruption of the signalling systems responsible for the synthesis and secretion of a number 
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of virulence factors. Although it is reasonable to conclude that resistance to QS would be 
selected in vivo during infection, when QS is involved in colonization, systemic spread and 
immune evasion (Defoirdt et al., 2010), a broad-spectrum combinatorial approach relying on 
the use of conventional antibiotics in combination with QSIs as an anti-virulence approach 
would diminish the chance of this event considerably. In a study investigating the vertical 
evolution of QSI resistance as well as the fitness conferred during bacterial social interaction, 
Mellbye & Schuster (2011) co-cultured wild type Pseudomonas aeruginosa together with QS 
mutants (mimicking a QSI-sensitive phenotype) in minimal medium containing either bovine 
serum albumin (BSA) or adenosine as a sole carbon source. Whereas BSA degradation 
requires extracellular proteases thus providing a social benefit, adenosine is metabolized 
intracellularly providing a benefit for the individual. QSI-sensitive mimics were found to 
retard the growth of wild-type QSI-resistant mimics when grown in BSA (public nutrient 
acquisition) indicating QSI resistance is unlikely to spread, especially during infection  
(Mellbye & Schuster, 2011). 
 
QSI targets 
Marine organisms have proven to be a rich source of natural compounds exhibiting quorum 
sensing inhibitory activity (Dobretsov et al., 2009, 2011; Saurav et al., 2017). In a study 
examining the inhibition of marine biofouling by QSI, of 78 bioactives tested from compound 
libraries derived from marine organisms including sponges, seaweeds, fungi, bacteria, 
tunicates and cyanobacteria,, more than half of them displayed QSI activity (Dobretsov et al., 
2011). In particular, the compounds hymenialdisin, demethoxy encecalin, microcolins A and 
B and kojic acid were found to inhibit the QS responses of the LuxR based reporter strains 
induced by N-3-oxo-hexanoyl-L-homoserine lactone at micromolar concentrations.  
The three components of the Gram negative AHL system are (1) the signal molecule 
generator, (2) the signal molecule itself and (3) the signal molecule receptor, representing the 
key targets of QSI for an anti-pathogenic drug approach (Rasmussen & Givskov, 2006).  
(1) In AHL-based Gram negative QS, an inactivation of the LuxI-type synthase would 
interrupt the synthesis of the relative AHL signal meaning that a significant threshold 
concentration could not be reached, with failure to activate the downstream genes responsible 
for virulence. In vitro, a few substrate analogues have been found to actively block the 
production of AHL. For example, analogues of S-adenosyl-L-methionine (SAM) have proven 
to be potent inhibitors of AHL synthase in P. aeruginosa (Rasmussen & Givskov, 2006). This 
has yet to be tested in vivo and remains the least investigated method of interfering with QS. 
(2) The signalling molecule itself constitutes another target to inhibit QS. The three 
principal strategies to de-activate a signalling molecule are metabolic, chemical and 
enzymatic degradation or inactivation. An alkaline pH causes the homoserine lactone ring 
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(Fig. 1) to open (Yates et al., 2002). For example, when a plant recognizes colonization by 
the pathogen Erwinia carotovora, which uses AHL-based QS to regulate the synthesis of 
virulence factors, the plant actively causes alkalinization at the site of attack resulting in 
lactonolysis. In addition to pH, several other factors including temperature and the length of 
the acyl side chain influence the opening of the lactone ring. An increase in temperature will 
accelerate the rate at which the ring opens, whereas the longer the side chain the slower will 
be the lactonolysis.  
 AHL lactonases are enzymes that catalyse the ring opening reaction of the lactone ring 
(Rasmussen & Givskov, 2006). Several Bacillus species are known to produce the lactonase 
enzyme AiiA (Dong et al., 2000), which is specific for the degradation of AHLs. Homologues 
of AiiA have also been found in other members of the Bacillus genus as well as members of 
the genera Pseudomonas, Arthrobacter and Klebsiella (Rasmussen & Givskov, 2006). This 
form of inactivation is reversible when the pH is acidic. Moreover, when the AiiA gene was 
heterologously expressed in P. aeruginosa PAO1 a significant inhibition of virulence gene 
production and swarming motility was achieved (Reimmann et al., 2002). Similarly, when 
cloned and expressed in Burkholderia species the AiiA gene coding for the lactonase enzyme 
significantly reduced virulence in this pathogen (Ulrich 2004; Wopperer et al., 2006). AHL 
acylases are another class of enzymes that can deactivate the Gram negative signalling 
molecule by cleaving the N-acyl bond of AHLs. Production of acylases has been reported in 
numerous genera of bacteria including Ralstonia, pseudomonads, and a Streptomyces (Lin et 
al., 2003). Bacteria such as Variovorax paradoxus and P. aeruginosa produce amino acylases 
responsible for the cleavage of the peptide bond of the signal molecule (Rasmussen & 
Givskov, 2006) and can use the products of this metabolism as their sole source of energy. It 
has been hypothesized that P. aeruginosa creates its own AHL-acylases to regulate its own 
QS system, possibly to evade detection during initial infection of a host (Sio et al., 2006). 
(3) In AHL-based QS, the LuxR transcription factor responsible for the regulation of 
downstream QS-dependent pathways represents another valid target for QSI. The use of small 
AHL analogues to prevent LuxR activation has proven a successful strategy to target LuxR 
type transcription factors (Suga & Smith, 2003). These analogues can displace the original 
AHL and cause activation of the LuxR-type protein, acting as competitive agonists (Schaefer 
et al., 1996). Synthetic analogues are developed in one of three ways: substitution in the acyl 
side chain leaving the ring unchanged; substitution and alteration to the lactone ring while the 
side chain remains unchanged; or extensive modification to both the side chain and lactone 
ring (Rasmussen & Givskov, 2006).   
Algal compounds – promising leads for the treatment of biofilm-related 
infections 
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Macroalgal bioactives such as sulphated polysaccharides and kahalalides have long been 
recognized for medical applications (Smit, 2004) and interest in them remains high (e.g. 
Barbosa et al., 2014). However, to date, only a few lead compounds and their synthetic 
derivatives have progressed to animal trials (e.g. Wu et al., 2004). 
Seaweeds rely on the coating/secretion of secondary metabolites (toxins and broad 
spectrum antimicrobials and antivirals) for protection against micro- and macro-colonizing 
organisms (Hentzer et al., 2003). For example, several halogenated furanone compounds 
isolated from the red seaweed Delisea pulchra (Givskov et al., 1996) are released at its 
surface at concentrations capable of inhibiting both prokaryotic and eukaryotic colonization 
(Steinberg et al., 2002). These compounds were shown to be QSI-active against a broad range 
of bacteria (Hentzer et al., 2002; Givskov et al., 1996). The furanones produced by Delisea 
accelerate the turnover of the LuxR transcription factor inhibiting QS-dependent gene 
expression in Gram negative bacteria (Manefield et al., 2002) and the capacity to synthesize 
such compounds is likely to have evolved as an antifouling strategy to preserve the surface of 
algal fronds from colonization by Gram negative marine bacteria. However, as they are 
brominated, their application in humans is limited, making it necessary to search for QSI from 
other natural sources (Zhu & Sun, 2008). Overall, macroalgae have yielded more than 3,000 
natural products, accounting for approximately 20% of marine natural compounds (Amsler, 
2008).  
 
Red seaweeds (Rhodophyta) 
Research on red seaweeds has discovered the majority of macroalgal secondary metabolites 
accounting for more than 1500 bioactives (Maschek & Baker, 2008)). With the exception of 
phlorotannins, which are unique to brown algae, red seaweeds synthesize all major classes of 
algal natural products (Blunt et al., 2016). Red algae primarily synthesize isoprenoid and 
acetogenin derivatives, as well as amino acid, shikimate and nucleic acid derivatives (Amsler, 
2008). Halogenated compounds underpin red algal chemistry, with over 90% of compounds 
reported to contain bromine or chlorine.  
 The genus Laurencia (Rhodomelaceae, Ceramiales) has been the subject of nearly 50% of 
the publications on red algal chemistry, producing a plethora of halogenated sesquiterpenes 
and C15 acetogenins, as well as higher terpenes (Davis & Vasanthi, 2011). Laurencia species 
occur widely on temperate and tropical coasts and are recognized as a rich source of novel 
secondary metabolites (Cabrita et al., 2010). Several of them display promising antimicrobial 
activity against a range of bacteria. For example, an unidentified species of Laurencia from 
Malaysia exerted potent antimicrobial activity against a range of marine bacteria; two 
halogenated C15 acetogenin compounds, elatol and iso-obtusol, were isolated from this alga 
and structurally elucidated based on spectroscopic data, confirming the potential of these 
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compounds as a source of pharmaceutically relevant bioactives (Vairappan et al., 2001). In 
extracts from L. majuscula, elatol inhibited six bacterial species, with significant 
antimicrobial activities against Staphylococcus epidermis, Klebsiella pneumonia and 
Salmonella sp.. Iso-obtusol, a polyhalogenated sesquiterpene produced by Laurencia obtusa, 
was found to display antimicrobial activity against several bacteria, and proved particularly 
active against K. pneumonia and Salmonella sp. (Vairappan, 2003). Interestingly, the 
antimicrobial activity of elatol and iso-obtusol was found to be equal or better than 
conventional antibiotics against K. pneumonia and Salmonella sp. through a bacteriostatic 
mode of action (Vairappan, 2003). Subsequently, Vairappan et al. (2010) discovered a novel 
brominated diterpene, 10-acetoxyangasiol, as well as four previously known metabolites, 
aplysidiol, cupalaurenol, 1-methyl-2,3,5-tribromoindole, and chamigrane epoxide in 
Laurencia sp. These compounds displayed strong antimicrobial activity against clinically 
relevant bacteria including Staphylococcus aureus, Streptococcus pyogenes, Salmonella sp. 
and Vibrio cholera.  
Members of the order Bonnemaisoniales also produce a diverse array of secondary 
halogenated metabolites displaying antimicrobial activity (Nash et al., 2005). Delisea, 
Asparagopsis, Bonnemaisonia and Ptilonia all synthesize a group of linear halogenated 
ketones and branched lactones. Amongst these, the fimbrolides, a group of halogenated 
furanones (Fig. 2) from Delisea pulchra from southeastern Australia, show QSI activity 
against a range of bacteria, functioning as an intracellular signal antagonist as well as 
accelerating LuxR turnover (Rasmussen et al., 2000; Manefield et al., 2002), and hence 
providing an antifouling defence (Kjelleberg & Steinberg, 2001). From a screen of 39 
macroalgae, Asparagopsis taxiformis extracts were shown to inhibit QS in C. violaceum 
CV026 bioreporter assays (Jha et al., 2013). Based on Ion Cyclotron Resonance Fourier 
Transformation Mass Spectrometry analysis of the QSI-active fraction, the authors proposed 
that the compound responsible for the QSI activity was 2-dodecanoyloxyethanesulfonate (Fig. 
6; Jha et al., 2013). 
Bonnemaisonia hamifera (Figs 7, 8) is native to Japan, was introduced into the North 
Atlantic Ocean prior to 1890 (Maggs & Stegenga, 1998) and is now widely distributed there. 
B. hamifera has a heteromorphic life cycle, alternating between a diploid filamentous 
“Trailliella” tetrasporophyte and a haploid gametophyte (Breeman et al., 1988). Like Delisea 
pulchra, B. hamifera produces an assortment of mono- and poly-halogenated bioactives 
including 2-heptanones, 2-heptanols, acetates and acids, some of which display antimicrobial 
activity (Siuda et al., 1975; Jacobsen & Madsen, 1978; McConnell & Fenical, 1979, Nylund 
et al., 2013; Enge et al., 2013).  
One of the main secondary metabolites, 1,1,3,3-tetrabromo-2-heptanone (Fig. 11), stored 
in specialized gland cells in the Trailliella phase, has an ecologically relevant role as an 
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antifouling agent against bacterial surface colonization. Natural surface concentrations (3.6 
µg cm
–2
) of 1,1,3,3-tetrabromo-2-heptanone applied to artificial panels significantly reduced 
the number of settled bacteria (Nylund et al., 2008). Moreover, organic extracts of B. 
hamifera show broad-spectrum antimicrobial activity at ecologically relevant concentrations 
(Nylund et al., 2005, 2008, 2013) confirming the potential of this species as a novel source of 
marine-derived antibiofilm compounds active against human pathogens.  The compound also 
acts as a chemical grazing deterrent (Enge et al., 2013), which is metabolically expensive to 
produce but protects the seaweed against bacteria as well as grazers (Nylund et al., 2013). 
It is interesting to note that several of these members of the Bonnemaisoniales found in 
Europe and containing halogenated compounds such as bromophenols (Paul et al., 2006) are 
aliens.  These compounds undoubtedly contribute to their invasive potential by deterring 
grazing and allowing the establishment of high biomass (Enge et al., 2013).  This is a clear 
indication that alien species are worth targeting in the search for new bioactives. QSI 
compounds have also been described from a few non-invasive red algae, such as Ahnfeltiopsis 
flabelliformis (Gigartinales) from Korea which has been shown to produce three AHL 
inhibitory compounds, floridoside (Fig. 3), betonicine (Fig. 4) and isethionic acid (Fig. 5) 
(Kim et al., 2007). 
 
Brown seaweeds (Phaeophyceae) 
Brown algae have also yielded a rich chemical diversity with more than 1,140 reported 
secondary metabolites. The most studied and representative bioactives of the brown seaweeds 
comprise diterpenes, phlorotannins, and small C11 acetogenins, all with very little 
halogenation (Blunt et al., 2007). Phlorotannins are distinguishing compounds of brown 
algae, with a wide range of activities of pharmacological interest including antimicrobial 
(Eom et al., 2012), antiviral (Ahn et al., 2004), antidiabetic (Lee & Jeon, 2013; Kang et al., 
2013), anti-inflammatory (Sugiura et al., 2013), anti-allergic (Sugiura et al., 2009), anti-
cancer (Lee et al., 2012), and anti-neurodegenerative diseases (Myung et al., 2005, Sathya et 
al., 2013; Jung et al., 2009; Heo et al., 2012) especially against Alzheimer’s disease (Yoon et 
al., 2008; Yoon et al., 2009i Ahn et al., 2012).  The ecological role of phlorotannins in brown 
seaweeds appears to include defence against epiphytes (Nakajima et al., 2016), as well as 
grazing deterrence (McClintock & Baker, 2001). 
Although many studies examining brown algal chemistry have focused on Dictyota 
(Dictyotaceae) and its wealth of terpenes (>250) (Munro & Blunt, 2005), several other genera 
display activities of pharmacological relevance. For example carotenoids from several brown 
algae have a wide range of bioactivities (Peng et al., 2011). The meroditerpenoid 
methoxybifurcarenone isolated from Cystoseira tamariscifolia displays antifungal activity 
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against three plant pathogenic fungi and antibacterial activity against Agrobacterium 
tumefaciens and E. coli (Bennamara et al., 1999). 
Halidrys siliquosa (family Sargassaceae) is a large temperate macroalga growing up to 
120 cm long in rock pools and sometimes as forests in the shallow subtidal zone. The 
bioactive potential of H. siliquosa was identified over four decades ago. Hornsey & Hide 
(1974, 1976) screened crude extracts of H. siliquosa against a series of opportunistic human 
pathogens and discovered antimicrobial activity against Staphylococcus aureus, E. coli, 
Bacillus subtilis, Streptococcus pyogenes and Proteus. Culioli et al. (2008) reported the 
antifouling activity of meroditerpenoids isolated from this species and identified nine 
tetraprenyltoluquinol-related metabolites exhibiting antifouling properties and inhibiting the 
growth of the marine bacteria Cobetia marina, Marinobacterium stanieri, Vibrio fischeri, 
Pseudoalteromonas haloplanktis. Non-cytotoxic concentrations of these meroditerpenoids 
were found to prevent the settlement of cyprids of Balanus amphitrite. H. siliquosa crude 
extract was active against the parasites Trypanosoma brucei rhodesiense, T. cruzi and 
Leishmania donovani and the bacterium Mycobacterium tubercolosis (Spavieri et al., 2010) 
highlighting the potential of this alga for the treatment of mycobacterial and protozoal 
infections. 
Busetti et al. (2015) reported antimicrobial and antibiofilm activity of methanolic 
extracts of H. siliquosa against clinically rel vant human pathogens of the genera 
Staphylococcus, Streptococcus, Enterococcus, Pseudomonas, Proteus, Stenotrophomonas, 
and Chromobacterium. Biofilms of S. aureus MRSA ATCC 33593 and S. aureus MRSA 
NCTC 10442 were found to be susceptible to H. siliquosa extract which achieved minimum 
biofilm eradication concentration (MBEC) values of 1.25 mg ml-1 and 5 mg ml-1 respectively. 
Active extracts showed no toxicity against wax moth (G. mellonella) larvae across a wide 
range of concentrations (Busetti et al., 2015). The activity of H. siliquosa methanolic extracts 
against the emerging pathogen Stenotrophomonas maltophilia suggests the production of 
bioactives with the potential to be used in a treatment strategy for cystic fibrosis as well as 
therapies for  Staphylococcus biofilm-related infections.  Moreover, the promising range of 
activities displayed by H. siliquosa organic extracts against clinically relevant, antibiotic-
resistant, human pathogens highlight this alga as a candidate for further studies focused on the 
isolation of antibiofilm compounds and antimicrobials for the treatment of infections 
involving multi-resistant pathogenic strains. 
 
Macroalgal microbiomes as a source of novel bioactives of pharmaceutical 
relevance 
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In recent years, several studies characterizing algal epiphytic bacterial communities (Figs 12-
13) have highlighted the presence of “core microbial species” in mutualistic or obligate 
association with their host (Singh et al., 2015). In particular, several bacterial epiphytes have 
been reported to produce bioactive compounds that can protect macroalgal surfaces from 
biofouling (Dobretsov & Qian, 2002). However, whereas several concerted studies have 
focused on characterizing the composition of the human microbiomes as well as deciphering 
the physiological significance of the host-microbe interactions underlying the mutualistic 
relationships therein, in seaweeds the microbiomes and the significance of their functional 
relationship with their hosts remain largely unexplored. The advent of culture-independent, 
DNA-based, metagenomic and transcriptomic methods has provided powerful new tools for 
the characterization of host-associated microbiomes as well as for the elucidation of the 
many, complex, yet often fundamental processes involved in host–microbe interactions, 
providing future studies the tools to investigate the functional microbiome involved in the 
often complex life cycles of macroalgae (Singh & Reddy, 2016). The discoveries deriving 
from such studies could assist in promoting fitness and productivity in macroalgal species of 
commercial interest through the modulation of a functionally active microbiome as well as 
providing enormous potential for the discovery of novel antibiofilm or QSI compounds of 
clinical relevance. 
For example, the epiphytic bacterium Pseudoalteromonas tunicata isolated from the 
surface of Ulva lactuca can hinder biofilm formation of competing Gram negative microbes 
through the synthesis of pigmented substances that inhibit LuxR-dependent transcriptional 
control through a similar mode of action to the furanones (McLean et al., 2004). Halobacillus 
salinus, a marine Gram positive bacterium isolated from a seagrass, synthesizes and releases 
QSI bioactives active against Gram negative strains (Teasdale et al., 2009) through  
competitive binding (Teasdale et al., 2009). These examples indicate that QS inhibition 
represents a natural, widespread, antifouling strategy evolved by marine organisms making 
marine ecosystems an ideal source for the discovery of QS inhibitors with potentially 
clinically relevant antibiofilm activity. 
In a recent study, an isolate belonging to the Pseudoalteromonas genus obtained from 
the algal fronds of the red seaweed Plocamium maggsiae displayed potent QSI activity 
against acyl homoserine lactone-based reporter strains (Busetti et al., 2014). The isolate’s 
filter-sterilized supernatant significantly diminished biofilm biomass both during biofilm 
formation as well as in pre-established, mature P. aeruginosa PAO1 biofilms causing a 0.97-
log reduction and a 2-log reduction in PAO1 biofilm viable counts in the biofilm formation 
and eradication assays. The crude organic extract obtained from this isolate displayed a 
minimum inhibitory concentration (MIC) of 2 mg ml-1 against PAO1 but failed to produce a 
minimum bactericidal concentration (MBC) confirming the lack of antimicrobial activity in 
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the extract at the concentrations tested. Sub-MIC concentrations of the crude organic extract 
were found to significantly reduce the quorum sensing (QS)-dependent production of the two 
virulence factors pyoverdin and pyocyanin in P. aeruginosa PAO1 without affecting growth. 
A combinatorial approach using tobramycin and the crude organic extract at 1 mg ml
-1
 against 
planktonic P. aeruginosa PAO1 increased the effectiveness of tobramycin by ten times, 
lowering its MIC against this pathogen from 0.75 to 0.075 mg ml
-1
 (Busetti et al., 2014). The 
results of this study confirm the efficacy of combinatorial strategies combining current  
antibiotic treatment with (non-antibiotic) QSI compounds derived from algal microbial 
epiphytes to improve the efficacy of current antibiotic treatments. 
 
Future perspectives 
The imminent global health threat of antimicrobial resistance with the realistic prospect of 
mankind entering a ‘post-antibiotic era’ has driven research into innovative therapeutic 
strategies relying on different targets and approaches for the treatment of microbial infections. 
The gradual elucidation of widespread bacterial communication (QS) systems regulated by 
small diffusible signal molecules as a means to coordinate group behaviours has 
revolutionized our classical conception of bacteria as unicellular and thus independent in 
nature. Targeting complex social behaviours, which include virulence and pathogenicity, 
regulated by chemical intra- and inter-species signal molecules which allow them to 
coordinate their behaviour at a community level, represents a novel target for non-antibiotic 
anti-infective chemotherapy. 
Marine organisms are known to produce a variety of QSIs that can thwart biofilm 
development of competing species (McClean & Winson et al., 1997; Bauer & Robinson 
2002; Saurav et al., 2017), representing an important resource for the isolation of novel 
“antipathogenic” antibiofilm compounds. Bacteria from algal microbiomes remain a 
relatively untapped source of novel candidate compounds displaying QSI activity with the 
potential to attenuate biofilm formation, virulence factor production or increase the 
antimicrobial susceptibility of clinically important pathogenic bacteria in the constant fight 
against emergence of multi-resistant microorganisms (Saurav et al., 2017).  
As in many other discovery and development programs in marine bioactives, there are a 
multitude of challenges associated with the biodiscovery and commercialization of 
macroalgal compounds as pharmaceutical agents. These include accessibility to the 
biodiversity, efficient screening, sustainable supply, variability in the spectrum and quantities 
of bioactives produced (due to factors such as seasonality and geographic distribution), 
elucidation of the mechanism of action, suitable pharmacokinetics/ pharmacodynamic 
parameters and ultimately costs associated with sustainable aquaculture and processing.  
Despite this, a significant body of early-stage biodiscovery research highlights marine 
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macroalgae as promising sources of novel antimicrobials, antibiofilm compounds, antivirals, 
anticancer, antimicrobial, anti-inflammatory and neuroprotective agents. 
Several studies have validated approaches that combine regular antibiotic agents with 
non-antibiotic compounds, such as QSIs, to enhance the effectiveness of present treatments, 
but have not yet moved to clinical trials. Drawing inspiration from nature, future studies could 
focus on evaluating the combinatorial effects of algal secondary metabolites with those 
produced by the core members of their bacterial microbiomes in an attempt to mimic the 
complex natural chemical mechanisms underlying the mutualistic symbiotic relationships in 
their environments. 
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Figure legends 
Figs 1-6. Molecular structures of acyl homoserine lactones and quorum sensing inhibitors 
isolated from marine algae.  Fig. 1. General structure of acyl homoserine lactones. Fig. 2. 
Halogenated furanones. Fig. 3. Floridoside. Fig. 4. Betonicine. Fig. 5. Isethionic acid. Fig. 6. 
2-dodecanoyloxyethanesulfonate. Figure adapted from Saurav et al. (2017). 
Figs 7-10. The red algae Bonnemaisonia hamifera and Bonnemaisonia asparagoides display 
strong antimicrobial activity against AHL quorum sensing bioreporter strain 
Chromobacterium violaceum. Algal samples were overlaid with C. violaceum in 0.5% agar 
prior to incubation. Fig. 7. B. hamifera washed in ddH2O. Fig. 8. B. hamifera pre-washed in 
70% ethanol; QSI activity not altered by ethanol wash. Fig. 9. B. asparagoides washed in 
ddH2O. Fig. 10. B. asparagoides washed in 70% ethanol, exhibiting significant loss of QSI 
activity which has been extracted by the ethanol wash. 
Fig. 11. Structure of 1,1,3,3-tetrabromo-2-heptanone, a poly-brominated 2-heptanone 
produced by Bonnemaisonia hamifera displaying antifouling properties. 
Figs 12-13. SEM of the epiphytic microbial colonisation of Halidrys siliquosa algal fronds.  
Fig. 12. Diatom embedded amongst diverse prokaryotes.  Fig. 13.  Three-dimensional 
structure of microbial biofilm. 
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Abstract 
 
Antimicrobial resistance (AMR) represents one of the major health threats faced by humanity 
in the coming decadesover the next few years. To prevent a global epidemic of antimicrobial-
resistant infections, the discovery of new antimicrobials and antibiotics, better anti-infection 
strategies and diagnostics, and changes to our current use of antibiotics have all become of 
paramount importance. Numerous studies investigating the bioactivities of seaweed extracts 
as well as their secondary and primary metabolites highlight the vast biochemical virtuosity 
diversity of seaweeds, with new modes of action making them ideal sources for the discovery 
of novel antimicrobial bioactive compounds of pharmaceutical interest. In recent years, 
researchers have focused on characterizing the endophytic and epiphytic microbiomes of 
various algal species in an attempt to elucidate host-microbe interactions as well as to 
understand the function of microbial communities. Although environmental and host-
associated factors crucially shape microbial composition, microbial mutualistic and obligate 
symbionts are often found to play a crucial fundamental role in regulating many aspects of 
host fitness involving ecophysiology and metabolism. In particular, algal “core” epiphytic 
bacterial communities play an important role in the protection of surfaces from biofouling, 
pathogens and grazers through the production of bioactive metabolites. Together, marine 
macroalgae and their associated microbiomes represent unique biological systems offering 
great potential for the isolation and identification of novel compounds and strategies to 
contrast the rise and dissemination of AMR. 
 
 
Key words: Algae, antimicrobials, antimicrobial resistance, bacteria, biofilms, epiphytes, 
marine, microbiome, pathogens, resistance, seaweeds 
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Introduction 
The emergence of antimicrobial resistance (AMR) in bacteria is an ancient natural process 
(D'Costa et al., 2011) resulting from the perpetual selection of new traits evolving as a result 
of mutation (Livermore, 2002), gradual increases in tolerance to sub-lethal concentrations of 
biocides (Scenihr, 2009) and horizontal gene transfer through transformation, transduction, 
recombination and conjugation events (Furuya & Lowy, 2006). Despite the undeniable 
contribution of antibiotic use to the development of a much healthier modern society, the 
release of large quantities of antibiotics into the environment as a result of their manufacture 
of antibiotics at an industrial global scale for use in the clinical setting and for agriculture and 
animal care and the consequent release of large quantities of antibiotics into the environment, 
has accentuatedheightenedincreased the selective pressure on bacterial human pathogens 
(Busetti et al., 2014). As a result, in the nosocomial clinical environment setting an evident 
clear relationshipthe between link betweening antibioticmicrobial use toandand the 
generationemergence and dissemination of resistant and multi-resistant strains is now 
evidentwell established (Hawkey, 2008; Wellington et al., 2013). The world faces an 
emerging epidemic of antibiotic-resistant infections, the second-leading cause of premature 
death worldwide (Spellberg et al., 2008), causing an estimated 700,000 deaths per year. A 
2014 review commissioned by the then British Prime Minister, David Cameron, highlighted 
that without Without effective solutions to confront AMR, by 2050, 10 million lives a year 
and more than 100 trillion USD$ of economic output world-wide will could be at risk due to 
the rise of drug-resistant infections (O'Neill, 2014).  In this article, we reviewThis article 
reviews the role of microbial biofilms in infection and the acquisition of resistance, examines 
the processes involved in the development and maintenance of microbial biofilms with a 
particular focus on the role of quorum sensing, discusses antimicrobial bioactives obtained 
from marine organisms, and reviews the current state of knowledge of marine macroalgae and 
their associated microbiomes as a source of antimicrobial chemical diversity. 
 
 
Biofilms  
Biofilms, communities consortia of surface-associated attached microbial cells embedded 
immersed in a self-secreted extracellular polymeric matrix (Costerton et al., 1978; Donlan, 
2002), represent constitute the predominant principal mode form of microbial growth in 
almost all natural and pathogenic environments and a widespread survival strategy amongst 
microorganisms (O'Toole, 2011; Nett et al., 2012). The National Institutes of Health (NIH) 
estimates that up to 80% of all human infections implicateinvolve microbial biofilms (Davies, 
2003; Wu et al., 2015). In fact, biofilm aetiology has been described as the root cause of a 
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majority of chronic and recurrent human infections and in almost all device-associated 
infections (Wu et al., 2015; Justin & Melander, 2009; Harrison et al., 2010; Hoiby et al., 
2011). Microbial biofilms provide constitute a favourable propitious environment 
ambientfavour both for spontaneous mutation and vertical evolution of resistance genes 
(Savage et al., 2013) as well as foras the intra- and inter-specific transmission and exchange 
of genetic elements components like plasmids harbouring resistance genes through horizontal 
gene transfer mechanisms (such as transformation, conjugation and transduction) and the 
consequent dissemination of resistance genes (Appelbaum, 2007). For example, within 
biofilms, bacteria have been shown to use transposable elements to acquire resistance and 
develop multi-resistance (Ready et al., 2002). The emergence of multiple-antibiotic-resistant 
strains amongst pathogens normally present in the nosocomial hospital environment is of 
particular concern and over a decade ago hospital-acquired infections were estimated to be 
responsible for an additional annual health care cost of £986 million in England and Wales 
alone (Plowman, 2000, Plowman et al., 2001). In light of the role of bacterial biofilms in 
infection and dissemination of AMR, the discovery isolation and characteriszation of novel 
antibiofilm compoundsbioactives and as well as the identification of novel therapeutic 
strategiesapproaches is crucial.  
Within biofilms, both Gram positive and Gram negative bacteria use quorum sensing 
(QS), a form type of cell-to-cell communication based on the release and detection of small 
signalling moleculescompounds, to coordinate multicellular behaviour and regulatecontrol a 
wide varietydiverse array of physiological activities (Papenfort & Bassler, 2016). Some 
bacterial species use QS to coordinate the expression transcription and translation of unlinked 
unrelated genetic loci. For exampleinstance, in the opportunistic human pathogen 
Pseudomonas aeruginosa uses, two hierarchically organiszed LuxI/LuxR type homologue 
pairs generally used by some Gram negative bacteria to produce and respond to acyl 
homoserine lactones, LasI/LasR and Rh1I/Rh1R, to, regulatecontrol 170-400 genes via a 
complex network (Hentzer et al., 2002; Schuster et al., 2003; Wagner et al., 2003; Parsek & 
Greenberg, 2005). The coordinated synchronized production synthesis and release of multiple 
proteinsgene products of diversewith substantially different functions suggests that QS is an 
adaptational adaptative response evolved to cope with conditions of high population density, 
such as for instance those encounteredfound in associations with plant and animal metazoan 
hosts (Swift et al., 2001).  
 
Biofilms in the marine environment 
In marine aquatic environments all unprotected submerged surfaces are rapidly colonized by a 
succession of marine organisms in a process known as biofouling (Callow & Callow, 2002). 
Biofouling begins with the adsorption of dissolved organic matter by newly available surfaces 
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and these “conditioned” surfaces are then rapidly colonized by prokaryotes and unicellular 
eukaryotes to form microbial biofilms (microfouling). In the marine environment, this stage is 
followed by macrofouling, the recruitment of invertebrate larvae and algal spores (Callow & 
Callow, 2002). Marine biofilms typically grow as diverse multi-species communities (Mueller 
et al., 2006). In the photic zone they are usually dominated by phototrophic microalgal 
consortia (Rao et al., 1997) and represent a crucial carbon source for other trophic levels, 
affecting mass transfer processes at the ecosystem level. 
Marine microbial biofilms play a crucial role in regulating the colonisation of surfaces 
by marine microorganisms, invertebrates and algae and in some cases might be 
responsible for inducing cellular metamorphosis in some larval types Marine microbial 
biofilms play a crucial role in regulating the settlement of a variety of marine 
microorganisms, invertebrates and algae and may promote cellular metamorphosis 
(Dobretsov et al., 2006). For example, tetrabromopyrrole, a compound produced by a 
Pseudoalteromonas bacterium, causes larval metamorphosis of the coral Acropora millepora 
(Tebben et al., 2011). The complexity of the modulations of these phenomena is paralleled by 
the extreme diversity in the distribution and composition of biological and chemical species 
found in marine microbial biofilms. Experiments using monospecific biofilms (Dobretsov et 
al., 2006; Wieczorek & Todd, 1998; Qian et al., 2007) have shown an influence on the 
activity of the marine flora ascribable to the production synthesis and release of 
antimicrobialbiotic compounds and as well as a range of stimulatory chemical cues signalling 
molecules that mostly remain so far mostlyin great part to be isolated and uncharacterized 
(Bowman, 2007).  
 
Bioactive compounds 
A “bioactive compound” can be defined is as a secondary metabolite which at low 
concentrations is either beneficial or harmful toexerts either beneficial or harmful effects on 
living organisms and is therefore of interest for potential industrial or medical applications 
(Rangel-Huerta et al., 2015needs reference) . More Bérdy (2005) reported that mOf the more 
than 1 million natural products have that haved been discovered from both terrestrial and 
marine living organisms (Table 1; Bérdy, 2005), of which 20-25% have haved shown 
antimicrobial, antifungal, anti-protozoan, anti-nematode, anticancer, antiviral or anti-
inflammatory properties (Bérdy, 2005; Penesyan et al., 2010 ; Newman and& Cragg, 2106). 
The diversity of natural compounds can be ascribed to the process of natural selection that has 
driven the evolution of molecules best suited to perform their biological activities (Koehn & 
Carter, 2005). 
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Natural products, chemicals produced by living organisms, are a traditional source of 
pharmacologically active compounds (Molinski et al., 2009), and continue to be a major 
source of inspiration for the majority of US FDAFood and Drug Administration (FDA)-
approved agents and for drug discovery and design. In fact, more than 60% of small molecule 
agents approved for use as drugs can be traced back to natural products such as aspirin 
(willow/birch), morphine (poppy), penicillin (fungus), Lovastatin (fungus), 
Adriamycin/dauxorubicin (bacterium) and Taxol™ (yew tree).  
Although the first indication of the presence in seawater of bacteria with an inhibitory 
effect against human pathogens such as Vibrio cholerae and Bacillus anthracis has been 
attributed to De Giaxa (1889; see Balcazar et al., 2007), the “modern” study of bioactives of 
marine origin emerged more than 70 years ago with the pioneering work of the Italian 
microbiologist Giuseppe Brotzu (Professor of Hygiene at the University of Cagliari, Italy). In 
1945 Brotzu grew cultures from seawater samples collected near a sewage outlet in Sardinia 
(Mediterranean Sea) and tested isolates for antibiotic activity. Strong inhibitory activity by 
the fungus Cephalosporium acremonium against a broad range of pathogens led to the 
discovery of the cephalosporin family of antibiotics (Bo, 2000). Rosenfield & Zobell (1947) 
carried out the first large-scale systematic study on the antibiotic activity of marine organisms 
against B. anthracis. Spongothymidine and spongouridine extracted and identified from the 
Caribbean sponge Tethya crypta (Bergmann & Feeney, 1950, 1951) were natural nucleoside 
analogues, structurally similar to the nucleosides of nucleic acids, but containing arabinose 
rather than the typical ribose. More importantly, these marine-derived compounds displayed 
unexpected antiviral activities and became the basis for the synthesis of several antiviral and 
anticancer drugs including AZT (zidovudine; Fowler et al., 2016), commercially known as 
Retrovir® (GlaxoSmithKline), the first drug for the treatment of HIV, and Acyclovir (sold as 
Zovirax®; Han et al., 2017), used to treat infections caused by the herpes simplex virus. 
Vidarabine®, also known as Ara-A, is a synthetic purine nucleoside analogue derived from 
the marine bacterium Streptomyces antibioticus isolated from T. crypta sponges (Agrawal et 
al, 2016), used typically as an opthalmic ointment for the treatment of acute herpes 
keratoconjunctivitis (Akkaya & Ozkurt, 2016) and recurrent superficial keratitis caused by 
HSV-1 and HSV-2.  
Today marine ecosystems still largely constitute an untapped resource for 
pharmaceutical and biotechnological biodiscovery. In the marine environment, whereas 
submerged non-living surfaces rapidly become macrofouled, the living surfaces of the 
majority of marine organisms remain are relativelycomparatively free from macrofouling and 
are, covered with a thin film of epibiotic bacteria (Armstrong et al., 2001). This is in part 
ascribable to metabolites effective as antifouling compounds and to the surface characteristics 
of marine organisms. Marine macroalgae (seaweeds) are known to utilize a plethora of 
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secondary metabolites to defend themselves from herbivores and bacterial colonization of 
their exposed surfaces. For example, halogenated furanones produced by the red alga Delisea 
pulchra display antibiofilm effects against Bacillus subtilis (Ren et al., 2002), Escherichia 
coli (Ren et al., 2001) and Pseudomonas aeruginosa (Hentzer et al., 2002). 
Microbes growing on the surface of a host can also contribute to the host’s overall 
antifouling strategy. For example, epibiotic bacteria found onthat colonisze the surface of 
larvae of some crustacean larvaes produce synthestize simple antibacterial antimicrobial 
compounds molecules that can protectdefend the larvae from fungal infections (Gil-Turnes et 
al., 1989). Bacteria isolated from the surface of a tunicate and grown as biofilms prevented 
hindered the settlement attachment of barnacle and tunicate larvae (Holmstrom et al., 1992). 
Moreover, the presence of epiphytic bacteria on the surface of seaweeds has been shown to be 
important for proper development, with atypical morphology observed in axenic culture (e.g. 
Marshall et al., 2006; Wichard et al., 2015), suggesting that macroalgae seaweeds and their 
epiphytic bacteria microbiome interactcollaborate as a unified functional entity or holobiont 
(reviewed by Egan et al., 2012). 
 
Quorum sensing inhibition as a novel strategy to attenuate bacterial virulence  
An emerging approach designed to attenuate bacterial virulence (i.e. the ability to cause 
damage to living organisms via the production of virulence factors such as enzymes and 
toxins) and limit the emergence of pathogenic traits relies on interfering with cell-to-cell 
communication, processes now commonly termed “quorum quenching” and “quorum sensing 
inhibition” (QSI)., In fact, the inability to co-ordinate communal behaviours can prevent 
bacterial pathogens from escaping or overcoming host immune responses so that bacteria fail 
to adapt to the host environment and do notand establishing an infection (Rasmussen & 
Givskov, 2006; Hentzer et al., 2003). Moreover, the ability to switch off virulence gene 
expression exogenously (Brackman et al., 2011) offers a novel strategy for the treatment or 
prevention of infection (Camara et al., 2002). Overall the use of QSIs can be 
consideredrepresents an “antivirulence” approach strategy based relying on the use 
exploitation of small molecules compounds with the capacitycapable of disarming pathogens 
thereby rendering them harmless within their host by targeting specificprecise factors (such as 
toxin function and delivery, virulence gene regulation, or cell adhesion) necessary for the 
successfulefficacious establishment of an infection, such as toxin function, toxin delivery, 
virulence gene regulation, or cell adhesion (Mellbye & Schuster, 2011). In certain species of 
bacteria, disruption of QS has been shown to affect biofilm formation (Irie & Parsek, 2008) 
and differentiation (Hardie & Heurlier, 2008), often rendering the biofilm more susceptible to 
treatment with biocides and antibiotics (Brackman & Coenye, 2015). For example, acylated 
homoserine lactone (AHL) QS mutants of Burkholderia cenocepacia and P. aeruginosa form 
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flatter, less structured biofilm (Diggle et al., 2007) and are drastically impaired in their ability 
to maintain cells within the biofilm (Huber et al., 2001; Tomlin et al., 2005; Yang et al., 
2009). Of relevance from a strategic therapeutic perspective, QSI-based treatments  have been 
shown to increases the susceptibility of bacterial biofilms to antibiotics both in vitro and in 
vivo. For example, a significantly higher greater percentage of infected wax moth Galleria 
mellonella larvae and C. elegans survived infection by P. aeruginosa and B. cenocepacia 
following combined treatment with antibiotic and QS inhibitors, compared to treatment with 
an antibiotic alone (Brackman et al., 2011).  
Paradoxically, tThe strong selective pressure imposed by the use of antibiotics 
antimicrobial use is particularly evident in the nosocomial clinicalnosocomialclinical 
environment setting makes this environment a fertile ground forwhere clear relationships 
between antimicrobial use and the emergence generation and spread of resistant and 
multiresistant strains  can be seen with a consequent rise in morbidity and mortality due to 
hospital- acquired infections (Hawkey, 2008). Since QS is not directly involved in essential 
processes, such as growth of the bacteriacell -division, one can reason that its inhibition will 
not generate a harshsevere selective pressure apt likely to produce result in the development 
of resistance (Rasmussen & Givskov, 2006; Sperandio, 2007; Kendall & Sperandio, 2007). In 
fact, the impairment of it has been shown that by inhibiting QS results in a disruption of the 
signalling systems controlling the production and releaseresponsible for the synthesis and 
secretion of a number of virulence factors is achieved. Although it is reasonable to conclude 
that resistance to QS  It has been hypothesized that the emergence of QS-resistance would be 
selected in vivo during infection, when QS is involved inever QS promotes colonization, 
systemic spread, andor immune evasion (Defoirdt et al., 2010),  although a broad-spectrum 
combinatorial approach relying on the use of conventional antibiotics in combination with 
QSIs as an anti-virulence approach would diminish the chance of this event considerably.joint 
antimicrobial/antivirulence approach lessens the likelihood of this considerably. In a study 
investigating the vertical evolution of QSI resistance as well as the fitness conferred during 
bacterial social interaction, Mellybye and Schuster (Mellbye & Schuster (, 2011)  co-cultured 
wild type Pseudomonas aeruginosa together with QS mutants (mimicking a QSI-sensitive 
phenotype) in minimal medium containing either bovine serum albumin (BSA) or adenosine 
as a sole carbon source. Whereas BSA degradation requires extracellular proteases thus 
providing a social benefit, adenosine is metabolized intracellularly providing a benefit for the 
individual. QSI-sensitive mimics were found to retard the growth of wild-type QSI-resistant 
mimics when grown in BSA (public nutrient acquisition) indicating QSI resistance is unlikely 
to spread, especially during infection (QSI-sensitive mimics) behaved as social cheaters 
delaying population growth and preventing enrichment of wild-type co-operators (QSI-
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resistant mimics) only when nutrient acquisition was public (extracellular), suggesting that 
QSI resistance is unlikely to spread (Mellbye & Schuster, 2011). 
 
QSI targets 
Marine organisms have proven to be a rich source A large number of natural compounds 
isolated from a variety of marine organisms have been shown to possessingexhibiting quorum 
sensing inhibitory activity (Dobretsov et al., 2009, 2011; Saurav et al., 2017). In a study 
examining the inhibition of marine biofouling by bacterial QSI, of 78 natural 
bioactivesproducts tested from chemical compound libraries containing compounds derived 
from marine organisms including (sponges, algaeseaweeds, fungi, bacteria, tunicates and 
cyanobacteria,) and terrestrial plants screened, more than half of them displayed QSI activity 
(Dobretsov et al., 2011). In particular, the compounds hymenialdisin, demethoxy encecalin, 
microcolins A and B and kojic acid were found to inhibit at micromolar concentrations 
inhibitedthe QS responses of the LuxR based reporter strains induced by N-3-oxo-hexanoyl-
L-homoserine lactone at micromolar concentrations.  
The three components of the Gram negative AHL system are (1) the signal molecule 
generator, (2) the signal molecule itself and (3) the signal molecule receptor, representing the 
key targets of QSI for an anti-pathogenic drug approach (Rasmussen & Givskov, 2006).  
(1) In AHL-based Gram negative QS, an inactivation of the LuxI-type synthase would 
block interrupt the production synthesis of the relative AHL signal molecule meaning that a 
significant threshold concentration could not be reached, with failure to activate the 
downstream genes responsible for virulence. In vitro, a few substrate analogues have been 
found to actively block the production of AHL. For example, analogues of S-adenosyl-L-
methionine (SAM) have proven to be potent inhibitors of AHL synthase in P. aeruginosa 
(Rasmussen & Givskov, 2006). This has yet to be tested in vivo and remains the least 
investigated method of interfering with QS. 
(2) The signalling molecule itself constitutes another target to inhibit QS.QS can be 
inhibited by targeting the signal molecule itself. The three principalmain strategies to de-
activate a signalling molecule are metabolic, chemical and enzymatic degradation or 
inactivation. An alkaline pH causes the homoserine lactone ring (Fig. 1) to open (Yates et al., 
2002). For example, wWhen a plant recognizes coloniszation by the pathogen Erwinia 
carotovora, which uses AHL-based QS to control regulate the expression synthesis of 
virulence factors, the plant actively causes alkalinization at the site of attack resulting in 
lactonolysis. In addition to pH, several other factors including temperature and the length of 
the acyl side chain influence the opening of the lactone ring. An increase in temperature will 
accelerate the rate at which the ring opens, whereas the longer the side chain the slower will 
be the lactonolysis.  
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 AHL lactonases are enzymes that catalyse the ring opening reaction of the lactone ring 
(Rasmussen & Givskov, 2006). Several Bacillus species have been foundare known to 
produce the lactonase enzyme AiiA (Dong et al., 2000), which is specific for the degradation 
of AHLs. Homologues of AiiA have also been found in other members of the Bacillus genus 
as well as members of the genera bacterial species including Pseudomonas,. aeruginosa,  
Arthrobacter species and Klebsiella pneumonia (Rasmussen & Givskov, 2006). This form of 
inactivation is reversible when the pH is acidic. Moreover, when the AiiA gene was 
heterologously expressed in expression of AHL lactonase in the human pathogen P. 
aeruginosa PAO1 resulted in largea significant decreases inhibition ofin virulence gene 
expression production and swarming motility was achieved (Reimmann et al., 2002). 
Similarly, when cloned and expressed in  Expression of AHL lactonase in Burkholderia 
species the AiiA gene coding for the lactonase enzyme significantly reducedcan also attenuate 
virulence in this pathogen (Ulrich 2004; Wopperer et al., 2006). AHL acylases, are another 
class of enzymes that can deactivate the Gram negative signalling molecule by cleavinge the 
N-acyl bond of AHLs. Production of acylases has, have been found reported in in several 
different types ofnumerous genera of bacteria including Ralstonia strain XJ12B, 
pseudomonads, and a Streptomyces species (Lin et al., 2003). Bacteria such as Variovorax 
paradoxus and P. aeruginosa produce amino acylases responsible for the cleavage of the 
peptide bond of the signal molecule (Rasmussen & Givskov, 2006) and can use the products 
of this metabolism as their sole source of energy.  Interestingly, it It has been hypothesized 
that P. aeruginosa creates its own AHL-acylases to regulate its own QS system, possibly to 
evade detection during initial infection of a host (Sio et al., 2006). 
(3) In AHL- based QS, The third target for QSI is the LuxR transcription factor 
responsible for the regulation of downstream QS-dependent pathways represents another 
valid target for QSI. The use of small AHL analogues to prevent LuxR activation has proven 
a successful strategy to target LuxR type transcription factors Small AHL analogues have 
been used to block the activation of LuxR (Suga & Smith, 2003). These analogues can 
displace the original AHL and cause activation of the LuxR-type protein, acting as 
competitive agonists (Schaefer et al., 1996). Synthetic analogues are developed in one of 
three ways: substitution in the acyl side chain leaving the ring unchanged; substitution and 
alteration to the lactone ring while the side chain remains unchanged; or extensive 
modification to both the side chain and lactone ring (Rasmussen & Givskov, 2006).   
Algal compounds -– promising leads for the treatment of biofilm-related 
infections 
Macroalgal bioactives such as sulphated polysaccharides and kahalalides have long been 
recognized for medical applications (Smit, 2004) and interest in them remains high (e.g. 
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Barbosa et al., 2014). However, to date, only a few lead compounds and their synthetic 
derivatives have progressed to animal trials (e.g. Wu et al., 2004). 
despite the many purported clinical applications for seaweed preparations, to date only a few 
small clinical trials have been conducted by a limited number of researchers. 
Seaweeds rely on the coating/secretion of secondary metabolites (toxins and broad 
spectrum antimicrobials and antivirals) for protection against micro- and macro-colonizing 
organisms (Hentzer et al., 2003). For example, several halogenated furanone compounds 
isolated from the red seaweed Delisea pulchra (Givskov et al., 1996) are released at its 
surface at concentrations capable of inhibiting both prokaryotic and eukaryotic colonization 
(Steinberg et al., 2002). These compounds were shown to be QSI- active against a broad 
range of bacteria (Hentzer et al., 2002; Givskov et al., 1996). Their production may have 
evolved in response to the negative impacts of AHL-dependent colonization of the surface of 
the algae by marine bacteria. These furanones produced by Delisea accelerate the turnover of 
the LuxR transcription factor inhibiting effectively antagonize AHLQS-dependent gene 
expression through accelerated degradation of the transcriptional activatorin Gram negative 
bacteria (Manefield et al., 2002) and the capacity to synthesize such compounds is likely to 
have evolved as an antifouling strategy to preserve the surface of algal fronds from the 
colonization by Gram negative marine bacteria.. However, as they are brominated, their 
application in humans is limited, making it necessary to search for QSI from other natural 
sources (Zhu & Sun, 2008). Overall, macroalgae have yielded more than 3,000 natural 
products, accounting for approximately 20% of marine natural compounds (Amsler, 2008; 
Table 1).  
 
Red seaweeds (Rhodophyta) 
Research on red seaweeds has discovered the majority of macroalgal secondary metabolites 
accounting for more than 1500 bioactives (Maschek , J.A. & Baker, B.J., 2008)Alex to add 
reference). With the exception of phlorotannins, which are unique to brown algae, red 
seaweeds synthesize all major classes of algal natural products (Blunt et al., 2016). Red algae 
primarily synthesize isoprenoid and acetogenin derivatives, as well as amino acid, shikimate 
and nucleic acid derivatives (Amsler, 2008). Halogenated compounds underpin red algal 
chemistry, with over 90% of compounds reported to contain bromine or chlorine.  
 The genus Laurencia (Rhodomelaceae, Ceramiales) accounts has been the subject of for 
nearly 50%half of the reports pubblications on red algal chemistry, producing a plethora of 
halogenated sesquiterpenes and C15 acetogenins characterized by the presence of halogen 
atoms in their chemical structures, as well as along with a few higher terpenes (C20 and 
greater; Davis & Vasanthi, 2011). Laurencia species occur widely on temperate and tropical 
coasts and are recognized as a rich source of novel secondary metabolites (Cabrita et al., 
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2010). Several of them display promising antimicrobial activity against a range of bacteria. 
An For example, an unidentified species of Laurencia from Malaysia exerted potent 
antimicrobial activity against a range of marine bacteria; two halogenated C15 acetogenin 
compounds, elatol and iso-obtusol, were isolated from this alga and structurally elucidated 
based on spectroscopic data, confirming the potential of these compounds as a source of 
pharmaceutically relevant bioactives (Vairappan et al., 2001). In extracts from L. 
majusculemajuscula, elatol inhibited six bacterial species, with significant antibacterial 
antimicrobial activities against Staphylococcus epidermis, Klebsiella pneumonia and 
Salmonella sp.., while iIso-obtusol, a polyhalogenated sesquiterpene produced by Laurencia 
obtusa, was found to exhibited antibacterialdisplay antimicrobial activity against four several 
bacteria, and proved particularly active againstwith significant activity against K. pneumonia 
and Salmonella sp. (Vairappan, 2003). Interestingly, the antimicrobial activity of 
Interestingly, elatol and iso-obtusol was found to be equal or better showed equal or better 
antibacterial activity than tested commercialconventional antibiotics while iso-obtusol 
displayed similar potency to commercial antibiotics against K. pneumonia and Salmonella sp. 
tThrough sp. Both compounds had a bacteriostatic mode of action against the tested bacteria 
(Vairappan, 2003).  Subsequently, Vairappan et al. (2010) found discovered a novel 
brominated diterpene, 10-acetoxyangasiol, as well as four previously known metabolites, 
aplysidiol, cupalaurenol, 1-methyl-2,3,5-tribromoindole, and chamigrane epoxide in 
Laurencia sp. Isolated These compoundsmetabolites exhibited potentdisplayed strong 
antibacterial antimicrobial activityies against clinically relevant bacteria including, 
Staphylococcus aureus, Staphylococcus sp., Streptococcus pyogenes, Salmonella sp. and 
Vibrio cholera.  
Members of the order Bonnemaisoniales also produce a diverse array of secondary 
halogenated metabolites displaying antimicrobial activity (Nash et al., 2005). Delisea, 
Asparagopsis, Bonnemaisonia and Ptilonia all synthesize a group of linear halogenated 
ketones and branched lactones. Amongst these, the fimbrolides, a group of halogenated 
furanones (Fig. 2) from Delisea pulchra from southeastern Australia, show QSI activity 
against a range of bacteria, functioning as an intracellular signal antagonist as well as 
accelerating LuxR turnover (Rasmussen et al., 2000; Manefield et al., 2002), and hence 
providing an antifouling defence (Kjelleberg & Steinberg, 2001). From a screen of 39 
macroalgae, Asparagopsis taxiformis extracts were shown to inhibit QS in C. violaceum 
CV026 bioreporter assays (Jha et al., 2013). The authors proposed, Bbased on Ion Cyclotron 
Resonance Fourier Transformation Mass Spectrometry (ICR-FT/MS) analysis of the QSI-
active fraction, the authors proposed that the compound responsible for the QSI activity was 
2-dodecanoyloxyethanesulfonate (Fig. 6; Jha et al., 2013). 
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Bonnemaisonia hamifera (Figs 7, 8) is native to Japan, was introduced into the North 
Atlantic Ocean prior to 1890 (Maggs & Stegenga, 1998) and is now widely distributed there. 
B. hamifera has a heteromorphic life cycle, alternating between a diploid filamentous 
“Trailliella” tetrasporophyte and a haploid gametophyte (Breeman et al., 1988). Like Delisea 
pulchra, B. hamifera produces an assortment of mono- and poly-halogenated compounds 
bioactives including 2-heptanones, 2-heptanols, acetates and acids, some of which display 
antimicrobial activity (Siuda et al., 1975; Jacobsen & Madsen, 1978; McConnell & Fenical, 
1979, Nylund et al., 2013; Enge et al., 2013).  
One of the main secondary metabolites, 1,1,3,3-tetrabromo-2-heptanone (Fig. 11), stored 
in specialized gland cells in the Trailliella phase, has an ecologically relevant role as an 
antifouling agent against bacterial surface colonization. Natural surface concentrations (3.6 
µg cm–2) of 1,1,3,3-tetrabromo-2-heptanone applied to artificial panels significantly reduced 
the number of settled bacteria (Nylund et al., 2008). Moreover, organiccrude extracts of B. 
hamifera show broad-spectrum antimicrobial activity against bacterial growth at ecologically 
relevant concentrations with ecological relevance (Nylund et al., 2005, 2008, 2013) 
confirming the potential of this species as a novel source of marine-derived antibiofilm 
compounds active against human pathogens.  The compound also acts as a chemical grazing 
deterrent (Enge et al., 2013), which is metabolically expensive to produce but protects the 
seaweed against bacteria as well as grazers (Nylund et al., 2013). 
It is interesting to note that several of these members of the Bonnemaisoniales found in 
Europe and containing halogenated compounds such as bromophenols (Paul et al., 2006), are 
aliens.  These compounds undoubtedly contribute to their invasive potential by deterring 
grazing and allowing the establishment of large high biomass (Enge et al., 2013).  This is a 
clear indication that alien species are worth targeting in the search for new bioactives. QSI 
compounds have also been described from a few non-invasive red algae, such as Ahnfeltiopsis 
flabelliformis (Gigartinales) from Korea which has been shown to produce three AHL 
inhibitory compounds, floridoside (Fig. 3), betonicine (Fig. 4) and isethionic acid (Fig. 5) 
(Kim et al., 2007). 
 
Brown seaweeds (Phaeophyceae) 
Brown algae have also yielded a rich chemical diversity with more than 1,140 reported 
secondary metabolites. The most studied and representative bioactives compounds of the 
brown seaweeds include comprise diterpenes, phlorotannins, and small C11 acetogenins, all 
with very little halogenation (Blunt et al., 2007). Phlorotannins are distinguishing compounds 
of brown algae, with a wide range of activities of pharmacological interest including 
antimicrobial (Eom et al., 2012), antiviral (Ahn et al., 2004), antidiabetic (Lee & Jeon, 2013; 
Kang et al., 2013), anti-inflammatory (Sugiura et al., 2013), anti-allergic (Sugiura et al., 
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2009), anti-cancer (Lee et al., 2012), and anti-neurodegenerative diseases (Myung et al., 
2005, Sathya et al., 2013; Jung et al., 2009; Heo et al., 2012) especially against Alzheimer’s 
disease (Yoon et al., 2008; Yoon et al., 2009i Ahn et al., 2012).  The ecological role of 
phlorotannins in brown seaweeds appears to include defence against epiphytes (Nakajima et 
al., 2016), as well as grazing deterrence (McClintock & Baker, 2001). 
Although many studies examining brown algal chemistry have focused on Dictyota 
(Dictyotaceae) and its wealth of terpenes (>250) (Munro & Blunt, 2005), several other genera 
display activities of pharmacological relevance. For example carotenoids from several brown 
algae have a wide range of bioactivities (Peng et al., 2011). The meroditerpenoid 
methoxybifurcarenone isolated from Cystoseira tamariscifolia displays antifungal activity 
against three plant pathogenic fungi and antibacterial activity against Agrobacterium 
tumefaciens and E. coli (Bennamara et al., 1999). 
Halidrys siliquosa (family Sargassaceae) is a large temperate macroalga growing up to 
120 cm long in rock pools and sometimes as forests in the shallow subtidal zone. The 
bioactive potential of H. siliquosa was identified over four decades ago. Hornsey & Hide 
(1974, 1976) screened crude extracts of H. siliquosa against a series of opportunistic human 
pathogens and discovered antimicrobial activity against Staphylococcus aureus, E. coli, 
Bacillus subtilis, Streptococcus pyogenes and Proteus. Culioli et al. (2008) reported the 
antifouling activity of meroditerpenoids isolated from this species and identified nine 
tetraprenyltoluquinol-related metabolites exhibiting antifouling properties and inhibiting the 
growth of the marine bacteria Cobetia marina, Marinobacterium stanieri, Vibrio fischeri, 
Pseudoalteromonas haloplanktis. (minimum inhibitory concentrations (MICs) < 2.5 µg ml-1) 
Non- cytotoxic concentrations of these meroditerpenoids were found to preventand 
preventing the settlement of cyprids of Balanus amphitrite (EC50 < 5 µg ml-1) at nontoxic 
concentrations (LC50 > 5 µg ml-1). A study of the antimycobacterial, antiprotozoal and 
cytotoxic potential of 21 brown algae (Phaeophyceae) from British and Irish waters found 
that H. siliquosa crude extract was found to be active active against the parasites 
Trypanosoma brucei rhodesiense, T. cruzi and Leishmania donovani and the bacterium 
Mycobacterium tubercolosis (Spavieri et al., 2010) highlighting the potential of this alga for 
the treatment of mycobacterial and protozoal infections..  
Busetti et al. (2015) reportedfound antimicrobial and antibiofilm activity of methanolic 
extracts of H. siliquosa against clinically relevant human pathogens of the genera 
Staphylococcus, Streptococcus, Enterococcus, Pseudomonas, Proteus, Stenotrophomonas, 
and Chromobacterium. . They reported MIC and minimum bactericidal concentration values 
(MBC) values of H. siliquosa methanolic extract ranging from 0.04-5 mg ml-1. Moreover, 
bBiofilms of S. aureus MRSA ATCC 33593 and S. aureus MRSA NCTC 10442 were found 
to be susceptible to H. siliquosa methanolic extract which acwhieved ith minimum biofilm 
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eradication concentration (MBEC) values of 1.25 mg ml-1 and 5 mg ml-1 respectively. AThe 
active extracts showed no toxicity against wax moth (G. mellonella) larvae across a wide 
range of concentrations up to the highest concentration tested (Busetti et al., 2015). The final 
antimicrobial activity exhibited by the crude extract using the disc diffusion assay or the MIC 
assay against MRSA ATCC 33593 is the result of the additive or synergistic activity of two 
distinct groups of compounds whereas the activity observed against C. violaceum ATCC 
12472 results from three distinct groups of compounds. The activity of H. siliquosa 
methanolic extracts against the emerging pathogen Stenotrophomonas maltophilia is study 
suggests the production of bioactives with the potential to be used in a treatment strategy for 
presence of compounds that could be used against the emerging cystic fibrosis pathogen 
Stenotrophomonas maltophilia as well as or in a treatment therapies for strategy for 
Staphylococcus biofilm-related infections. The vast arsenal of bioactive compounds produced 
by H. siliquosa renders this organism another ideal subject for the isolation and 
characterization of bioactive compounds displaying antimicrobial or antibiofilm activity 
against clinically relevant human pathogens. Moreover, the promising range of activities 
displayed by H. siliquosa organic extracts against clinically relevant, antibiotic-resistant, 
human pathogens re-electhighlight this alga as a candidate for further studies focused on the 
isolation of antibiofilm compounds and antimicrobials for the treatment of infections 
involving resistant multi-resistant pathogenic strains. 
 
Macroalgal microbiomes as a source of novel bioactives of pharmaceutical 
relevance 
In recent years, several studies characterizing algal epiphytic bacterial communities (Figs 12-
13) have highlighted the presence of “core microbial species” in mutualistic or obligate 
association with their host (Singh et al., 2015). In particular, several bacterial epiphytes have 
been reported to produce bioactive compounds that can protect macroalgal surfaces from 
biofouling (Dobretsov and& Qian, 2002). However, whereas several concerted studies have 
focused on characteriszing the composition of the human microbiomes as well as deciphering 
the physiological significance of the host-microbe interactions underlying the mutualistic 
relationships therein, in seaweeds the characterisation of microbiomes and the significance of 
their functional relationship with their hosts remain largely unexplored. The advent of 
culture-independent, DNA-based, metagenomic and transcriptomic methods has provided 
powerful new tools for the characteriszation of host-associated microbiomes as well as for the 
elucidation of the many, complex, yet often fundamental processes involved in host-–microbe 
interactions, providing future studies the tools to investigate the functional microbiome 
involved in the often complex life cycles of macroalgae (Singh and& Reddy, 2016). The 
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discoveries deriving from such studies could assist in promoting fitness and productivity in 
macroalgal species of commercial interest through the modulation of a functionally active 
microbiome as well as providing enormous potential for the discovery of novel antibiofilm or 
QSI compounds of clinical relevance. Epiphytic bacterial communities have been reported to 
play an important role in protecting macroalgal surfaces from biofouling microorganisms 
through production of biologically active metabolites. However, in contrast to the microbial 
studies associated with human skin and gut and plants that have significantly advanced our 
knowledge on microbiomes and their functional interactions with the host, in seaweeds the 
precise composition of microbiomes and their functional partnership with their hosts remain 
relatively unknown. Therefore, it is imperative to investigate the functional microbiome that 
is closely involved in the life cycles of macroalgae using high-throughput techniques 
(metagenomics and metatranscriptomics). The findings from such investigations would help 
in promoting health and productivity in macroalgal species through regulation of a 
functionally active microbiome as well as providing enormous potential for the isolation of 
novel antibiofilm or QSI compounds of clinical relevance. 
For example,For example, the green alga the epiphytic bacterium Pseudoalteromonas 
tunicata isolated from the surface of Ulva lactuca can hinderrelies on the epiphytic bacterium 
Pseudoalteromonas tunicata to block biofilm formation of competing Gram negative 
microbes through the synthesis of pigmented substances that inhibit LuxR-dependent AHL-
dependant transcriptional control in through a comparable fashionsimilar mode of action to 
the furanones (McLean et al., 2004). Halobacillus salinus, a marine Gram positive bacterium 
isolated from a seagrass, secretes synthesizes and releases QSI secondary 
metabolitesbioactives capable of quenching QS-controlled behaviours inactive against Gram 
negative strains (Teasdale et al., 2009) through  competitive binding. It is believed that these 
nontoxic metabolites may act as antagonists of bacterial QS by competing with AHLs for 
receptor binding (Teasdale et al., 2009). These examples indicate that QS inhibition 
represents a natural, widespread, antifoulingantimicrobial strategy utilized evolved by marine 
organisms with significant impact on biofilm formation, making marine ecosystems an ideal 
source for the discovery of QS inhibitors with potentially clinically relevant antibiofilm 
activity. 
In a recent study, an isolate belonging to the Pseudoalteromonas sp.genus 
isolateddobtained from the surface algal fronds of the red alga seaweed Plocamium maggsiae 
displayed strong potent quorum sensing inhibitory (QSI) activity against acyl homoserine 
lactone (AHL)-based Chromobacterium violaceum reporter strains ATCC 12472 and CV026 
(Busetti et al., 2014). The isolate’s filter-steriliszed supernatant significantly reduced 
diminished biofilm biomass both during biofilm formation (by 63%) as well as nd in pre-
established, mature P. aeruginosa PAO1 biofilms (by 33%) causing a 0.97-log reduction 
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(−89%) and a 2-log reduction (−99%) in PAO1 biofilm viable counts in the biofilm formation 
and the biofilm eradication assays. The crude organic extract obtained from this isolateextract 
displayehad a minimum inhibitory concentration (MIC) of 2 mg ml-1 against PAO1 but failed 
to no produce a minimum bactericidal concentration (MBC) confirming the lack of 
antimicrobial activity in the extract at the concentrations tested. Sub-MIC concentrations (1 
mg ml-1) of KS8 the crude organic extract were found to significantly reduced the quorum 
sensing (QS)-dependent production of both the two virulence factors pyoverdin and 
pyocyanin in P. aeruginosa PAO1 without affecting growth. A combinatorial approach using 
tobramycin and the crude organic extract at 1 mg ml-1 against planktonic P. aeruginosa PAO1 
increased the efficacy effectiveness of tobramycin ten-foldby ten times, decreasing lowering 
the its MIC against this pathogen from 0.75 to 0.075 mg ml-1 (Busetti et al., 2014). These 
results of this study confirmdata support the validity efficacy of combinatorial approaches 
strategies combining conventional current  antibiotic treatmentherapy with (non-antibiotic) 
QSI compounds derived from algal microbial epiphytes to improve the efficacy of current 
antibiotic treatments. 
 
ConclusionsFuture perspectives 
The imminent global health threat of antimicrobial resistance with the realistic prospect of 
mankind entering a ‘post-antibiotic era’ has spurred driven research into novel innovative 
therapeutic strategies based relying on new different targets and approaches for the treatment 
of microbial infections. The discovery gradual elucidation of widespread bacterial 
communication (QS) systems regulated by small diffusible signal molecules as a means to 
coordinate group behaviours has revolutionized our classical conception of bacteria as 
unicellular and thus independent in nature. Targeting complex social behaviours, which 
include virulence and pathogenicity, regulated by chemical intra- and inter-species signal 
molecules which allow them to coordinate their behaviour at a community level, represents a 
novel target for non-antibiotic anti-infective chemotherapy. 
Marine organisms are known to produce a variety of QSIs that can interfere thwart with 
the biofilm formation development of competing species (McClean & Winson et al., 1997; 
Bauer & Robinson 2002; Saurav et al., 2017), representing an important resource for the 
isolation of novel “antipathogenic” antibiofilm compounds. Bacteria from algal microbiomes 
remain a relatively untapped source of novel candidate compounds displaying QSI activity 
with the potential to attenuate biofilm formation, virulence factor production or increase the 
antimicrobial susceptibility of clinically important pathogenic bacteria in the constant fight 
against emergence of multi-resistant microorganisms (Saurav et al., 2017).  
As in many other discovery and development programs in marine bioactives, there are a 
multitude of challenges associated with the biodiscovery and commercialization of 
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macroalgal compounds as pharmaceutical agents. These include accessibility to the 
biodiversity, efficient screening, sustainable supply, variability in the spectrum and quantities 
of bioactives produced (due to factors such as seasonality and geographic distribution), 
elucidation of the mechanism of action, suitable pharmacokinetics/ pharmacodynamic 
parameters and ultimately costs associated with sustainable aquaculture and processing.  
Despite this, a significant body of early-stage biodiscovery research highlights marine 
macroalgae as promising sources of novel antimicrobials, antibiofilm compounds, antivirals, 
anticancer, antimicrobial, anti-inflammatory and neuroprotective agents. 
Several studies have validated approaches that combine conventional regular antibiotic 
agents with non-antibiotic compounds, such as QSIs, to enhance the effectivenessicacy of 
present current treatments, but have not yet moved to clinical trials. Drawing inspiration from 
nature, future studies could focus on evaluating the combinatorial effects of algal secondary 
metabolites with those produced by the core members of their bacterial microbiomes in an 
attempt to mimic the complex natural chemical mechanisms underlying the mutualistic 
symbiotic relationships in their environments. 
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Table 1. Approximate number of known natural products, bioactives and antibiotics. Adapted 
from Bérdy (2005, table 1). 
 
Source Known compounds Bioactives Antibiotics 
Total natural products > 1 million 200000 to 250000 25000 to 30000 
Microorganisms (bacteria, 
Actinomycetales and fungi) 
>  50000 22000 to 23000 ca. 17000 
Algae, seaweeds, lichens 3000 to 5000 1500 to 2000 ca. 1000 
Higher plants 500000 to 600000 ca. 100000 10000 to 12000 
Protozoa Several hundreds 100 to 200 ca. 50 
Invertebrates ca. 100000 No data ca. 500 
Marine animals 20000 to 25000 7000 to 8000 3000 to 4000 
Insects/worms/etc. 8000 to 10000 800 to 1000 150 to 200 
Vertebrates 200000 to 250000 50000 to 70000 ca. 1000 
 
Data were assembled by Bérdy (2005) from his database including nearly one million 
references and drawing on information from other databases. Non-marine taxa (higher plants, 
vertebrates) are much better known than marine organisms (algae, marine animals, worms). 
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Figure legends 
Figs 1-6. Molecular structures of acyl homoserine lactones and quorum sensing inhibitors 
isolated from marine algae.  Fig. 1. General structure of acyl homoserine lactones. Fig. 2. 
Halogenated furanones. Fig. 3. Floridoside. Fig. 4. Betonicine. Fig. 5. Isethionic acid. Fig. 6. 
2-dodecanoyloxyethanesulfonate. Figure adapted from Saurav et al. (2017). 
Figs 7-10. The red algae Bonnemaisonia hamifera and Bonnemaisonia asparagoides display 
strong antimicrobial activity against AHL quorum sensing bioreporter strain 
Chromobacterium violaceum. Algal samples were overlaid with C. violaceum in 0.5% agar 
prior to incubation. Fig. 17. B. hamifera washed in ddH2O. Fig. 28. B. hamifera pre-washed 
in 70% ethanol; QSI activity not altered by ethanol wash. Fig. 39. B. asparagoides washed in 
ddH2O. Fig. 410. B. asparagoides washed in 70% ethanol, exhibiting significant loss of QSI 
activity which has been extracted by the ethanol wash. 
Fig. 11. Structure of 1,1,3,3-tetrabromo-2-heptanone, a poly-brominated 2-heptanone 
produced by Bonnemaisonia hamifera displaying antifouling properties. 
Figs 12-, 13. SEM of the epiphytic microbial colonisation of Halidrys siliquosa algal fronds.  
Fig. 12. Diatom embedded amongst diverse prokaryotes.  Fig. 13.  Three-dimensional 
structure of microbial biofilm. 
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